Price Alert

Aligos Therapeutics Inc. (ALGS)

NASDAQ: ALGS · Real-Time Price · USD

11.34

0.60 (5.59%)

At close: Sep 05, 2025, 3:59 PM

11.17

-1.50%

After-hours: Sep 05, 2025, 04:33 PM EDT

5.59% (1D)

Bid	10.9
Market Cap	69.76M
Revenue (ttm)	3.17M
Net Income (ttm)	-74.18M
EPS (ttm)	-13.2
PE Ratio (ttm)	-0.86
Forward PE	-1.47
Analyst	Buy

Ask	11.8
Volume	63,571
Avg. Volume (20D)	92,670
Open	10.79
Previous Close	10.74
Day's Range	10.48 - 11.40
52-Week Range	3.76 - 46.80
Beta	2.80

About ALGS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ALGS

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ALGS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Aligos Therapeutics Inc. is scheduled to release its earnings on Nov 5, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 weeks ago

+13.9%

Aligos Therapeutics shares are trading higher afte... Unlock content with Pro Subscription

6 months ago

-19.55%

Aligos Therapeutics shares are trading lower after the company reported Q4 financial results and missed its EPS estimate.

News

2 weeks ago · zacks.com

Wall Street Analysts Predict a 983.24% Upside in Aligos Therapeutics (ALGS): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 983.2% in Aligos Therapeutics (ALGS). While the effectiveness of this highly sought-after metric is questionabl...

1 month ago · zacks.com

Aligos Therapeutics, Inc. (ALGS) Reports Q2 Loss, Misses Revenue Estimates

Aligos Therapeutics, Inc. (ALGS) came out with a quarterly loss of $1.53 per share versus the Zacks Consensus Estimate of a loss of $2.35. This compares to earnings of $0.75 per share a year ago.